NT5E and pneumonitis: As a consequence of targeted anti-CD73 therapy, both cell types could show a more pronounced pro-inflammatory phenotype and a series of cytokines, such as TNFα, IL-1β, IL-6, and TGFβ, could be released and enhance pneumonitis (Yarosz and Chang, 2018).